Key facts
- This page summarizes Kathi Niffenegger's Form 4 filing for Edesa Biotech, Inc. (EDSA).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2022, 15:27.
Kathi Niffenegger - 02 Nov 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- EDSA
- Reported as of
- 02 Nov 2022
- Net transaction value
- +$9,999
- SEC form
- 4
- Accepted by SEC
- 04 Nov 2022, 15:27:06 UTC
- Prior SEC filing
- 07 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathi Niffenegger
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kathi Niffenegger filed Form 4 for Edesa Biotech, Inc. (EDSA) on 04 Nov 2022.
Change
- Previous filing in this sequence was filed on 07 Mar 2022.
- Current net transaction value: +$9,999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EDSA
transaction
Common Shares
Award
- Transaction value
- $9,999
- Shares
- +8,888
- Change %
- +486%
- Price
- $1.12
- Shares after
- 10,715
- Date
- 02 Nov 2022
- Ownership
- By Trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EDSA
transaction
Derivative
Common Share Warrants (Right to Buy)
Award
- Transaction value
- Shares
- +4,444
- Change %
- Price
- Shares after
- 4,444
- Date
- 02 Nov 2022
- Ownership
- By Trust
- Underlying class
- Common Shares
- Underlying amount
- 4,444
- Exercise price
- $1.50
- Footnotes
- F1, F2
EDSA
transaction
Derivative
Common Share Warrants (Right to Buy)
Award
- Transaction value
- Shares
- +4,444
- Change %
- Price
- Shares after
- 4,444
- Date
- 02 Nov 2022
- Ownership
- By Trust
- Underlying class
- Common Shares
- Underlying amount
- 4,444
- Exercise price
- $1.00
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
Footnote F2
Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date.
Footnote F3
Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date.